Return On Equity of Kezar Life Sciences, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kezar Life Sciences, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Kezar Life Sciences, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -63%, a 4.7% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Return On Equity for 2024 was -59%, a 28% decline from 2023.
  • Kezar Life Sciences, Inc. annual Return On Equity for 2023 was -46%, a 82% decline from 2022.
  • Kezar Life Sciences, Inc. annual Return On Equity for 2022 was -25%, a 32% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Kezar Life Sciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -63% -2.8% -4.7% 01 Jul 2025 30 Sep 2025
Q2 2025 -64% -9% -17% 01 Apr 2025 30 Jun 2025
Q1 2025 -62% -12% -24% 01 Jan 2025 31 Mar 2025
Q4 2024 -59% -13% -28% 01 Oct 2024 31 Dec 2024
Q3 2024 -60% -24% -65% 01 Jul 2024 30 Sep 2024
Q2 2024 -54% -23% -71% 01 Apr 2024 30 Jun 2024
Q1 2024 -50% -23% -87% 01 Jan 2024 31 Mar 2024
Q4 2023 -46% -21% -82% 01 Oct 2023 31 Dec 2023
Q3 2023 -36% -11% -42% 01 Jul 2023 30 Sep 2023
Q2 2023 -32% -3% -10% 01 Apr 2023 30 Jun 2023
Q1 2023 -27% +7% +21% 01 Jan 2023 31 Mar 2023
Q4 2022 -25% +12% +32% 01 Oct 2022 31 Dec 2022
Q3 2022 -25% +13% +34% 01 Jul 2022 30 Sep 2022
Q2 2022 -29% +5.5% +16% 01 Apr 2022 30 Jun 2022
Q1 2022 -34% -3.7% -12% 01 Jan 2022 31 Mar 2022
Q4 2021 -37% -8.1% -28% 01 Oct 2021 31 Dec 2021
Q3 2021 -39% -7% -22% 01 Jul 2021 30 Sep 2021
Q2 2021 -34% +0.03% +0.09% 01 Apr 2021 30 Jun 2021
Q1 2021 -30% +8.9% +23% 01 Jan 2021 31 Mar 2021
Q4 2020 -29% +9.7% +25% 01 Oct 2020 31 Dec 2020
Q3 2020 -32% +0.21% +0.66% 01 Jul 2020 30 Sep 2020
Q2 2020 -34% -7.8% -30% 01 Apr 2020 30 Jun 2020
Q1 2020 -39% -16% -69% 01 Jan 2020 31 Mar 2020
Q4 2019 -39% -9.1% -31% 01 Oct 2019 31 Dec 2019
Q3 2019 -32% +12% +28% 01 Jul 2019 30 Sep 2019
Q2 2019 -26% 01 Apr 2019 30 Jun 2019
Q1 2019 -23% 01 Jan 2019 31 Mar 2019
Q4 2018 -30% 01 Oct 2018 31 Dec 2018
Q3 2018 -44% 01 Jul 2018 30 Sep 2018

Kezar Life Sciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -59% -13% -28% 01 Jan 2024 31 Dec 2024
2023 -46% -21% -82% 01 Jan 2023 31 Dec 2023
2022 -25% +12% +32% 01 Jan 2022 31 Dec 2022
2021 -37% -8.1% -28% 01 Jan 2021 31 Dec 2021
2020 -29% +9.7% +25% 01 Jan 2020 31 Dec 2020
2019 -39% -9.1% -31% 01 Jan 2019 31 Dec 2019
2018 -30% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.